Literature DB >> 17175452

A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon's contribution to long-term survival in pancreatic cancer.

Thomas J Howard1, Joseph E Krug, Jian Yu, Nick J Zyromski, C Max Schmidt, Lewis E Jacobson, James A Madura, Eric A Wiebke, Keith D Lillemoe.   

Abstract

Pancreatic cancer has a poor prognosis with complete surgical resection being the only therapy to offer a realistic chance for long-term survival. The aim of this study is to identify surgery-related variables that influence long-term survival. Between 1990 and 2002, 226 consecutive patients (mean age of 64+/-11 years) had resection for pancreatic adenocarcinoma. Prognostic variables in these patients were analyzed using univariate and multivariate analysis. Two hundred four patients (90%) had pancreaticoduodenectomy, 13 patients (6%) had distal pancreatectomy, and 9 patients (4%) had a TP. Stage I disease was present in 50 (22%), stage II disease in 170 (75%), and stage III disease in 6 (3%). R0 resections were achieved in 70%. Operative morbidity was 36% and 30-day mortality was 6%. Actual 1-year, 3-year, and 5-year survival rates were 49% (n=111), 14% (n=31), and 4% (n=9). Using multivariate analysis: tumor size, tumor differentiation, obtaining an R0 resection, and lack of postoperative complications were variables associated with long-term survival. Long-term survival in patients with pancreatic cancer after resection remains poor. Achieving a margin negative resection (R0) with no postoperative complications are prognostic variables that can be affected by the surgeon.

Entities:  

Mesh:

Year:  2006        PMID: 17175452     DOI: 10.1016/j.gassur.2006.09.008

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  36 in total

Review 1.  Survival statistics gone awry: pancreatic cancer, a case in point.

Authors:  Birgir Gudjonsson
Journal:  J Clin Gastroenterol       Date:  2002-08       Impact factor: 3.062

Review 2.  Pancreaticoduodenectomy.

Authors:  Andrew L Warshaw; Sarah P Thayer
Journal:  J Gastrointest Surg       Date:  2004 Sep-Oct       Impact factor: 3.452

Review 3.  Treatment for pancreatic cancer: current therapy and continued progress.

Authors:  A Craig Lockhart; Mace L Rothenberg; Jordan D Berlin
Journal:  Gastroenterology       Date:  2005-05       Impact factor: 22.682

4.  Cancer statistics, 2005.

Authors:  Ahmedin Jemal; Taylor Murray; Elizabeth Ward; Alicia Samuels; Ram C Tiwari; Asma Ghafoor; Eric J Feuer; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2005 Jan-Feb       Impact factor: 508.702

5.  Pancreaticoduodenectomy with vascular resection: margin status and survival duration.

Authors:  Jennifer F Tseng; Chandrajit P Raut; Jeffrey E Lee; Peter W T Pisters; Jean-Nicolas Vauthey; Eddie K Abdalla; Henry F Gomez; Charlotte C Sun; Christopher H Crane; Robert A Wolff; Douglas B Evans
Journal:  J Gastrointest Surg       Date:  2004-12       Impact factor: 3.452

6.  Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group.

Authors:  S Pedrazzoli; V DiCarlo; R Dionigi; F Mosca; P Pederzoli; C Pasquali; G Klöppel; K Dhaene; F Michelassi
Journal:  Ann Surg       Date:  1998-10       Impact factor: 12.969

7.  Observations on the developmental patterns and the consequences of pancreatic exocrine adenocarcinoma. Findings of 154 autopsies.

Authors:  C Mao; D R Domenico; K Kim; D J Hanson; J M Howard
Journal:  Arch Surg       Date:  1995-02

Review 8.  Carcinoma of the pancreas: critical analysis of costs, results of resections, and the need for standardized reporting.

Authors:  B Gudjonsson
Journal:  J Am Coll Surg       Date:  1995-12       Impact factor: 6.113

9.  Results of resection for cancer of the exocrine pancreas: a study from the French Association of Surgery.

Authors:  H Baumel; M Huguier; J C Manderscheid; J M Fabre; S Houry; H Fagot
Journal:  Br J Surg       Date:  1994-01       Impact factor: 6.939

10.  Efficacy of venous reconstruction in patients with adenocarcinoma of the pancreatic head.

Authors:  Thomas J Howard; Nicholas Villanustre; Seth A Moore; John DeWitt; Julia LeBlanc; Dean Maglinte; Lee McHenry
Journal:  J Gastrointest Surg       Date:  2003-12       Impact factor: 3.267

View more
  104 in total

1.  Multi-institutional analysis of pancreatic adenocarcinoma demonstrating the effect of diabetes status on survival after resection.

Authors:  Robert M Cannon; Ryan LeGrand; Ryaz B Chagpar; Syed A Ahmad; Rebecca McClaine; Hong Jin Kim; Christopher Rupp; Cliff S Cho; Adam Brinkman; Sharon Weber; Emily R Winslow; David A Kooby; Carrie K Chu; Charles A Staley; Ian Glenn; William G Hawkins; Alexander A Parikh; Nipun B Merchant; Kelly M McMasters; Robert C G Martin; Glenda G Callender; Charles R Scoggins
Journal:  HPB (Oxford)       Date:  2012-01-19       Impact factor: 3.647

2.  Potential contribution of preoperative neoadjuvant concurrent chemoradiation therapy on margin-negative resection in borderline resectable pancreatic cancer.

Authors:  Chang Moo Kang; Yong Eun Chung; Jeong Youp Park; Jin Sil Sung; Ho Kyoung Hwang; Hye Jin Choi; Hyunki Kim; Si Young Song; Woo Jung Lee
Journal:  J Gastrointest Surg       Date:  2011-12-20       Impact factor: 3.452

3.  Pancreatic adenocarcinoma.

Authors:  Margaret A Tempero; J Pablo Arnoletti; Stephen Behrman; Edgar Ben-Josef; Al B Benson; Jordan D Berlin; John L Cameron; Ephraim S Casper; Steven J Cohen; Michelle Duff; Joshua D I Ellenhorn; William G Hawkins; John P Hoffman; Boris W Kuvshinoff; Mokenge P Malafa; Peter Muscarella; Eric K Nakakura; Aaron R Sasson; Sarah P Thayer; Douglas S Tyler; Robert S Warren; Samuel Whiting; Christopher Willett; Robert A Wolff
Journal:  J Natl Compr Canc Netw       Date:  2010-09       Impact factor: 11.908

Review 4.  Borderline resectable pancreatic cancer: definitions and management.

Authors:  Nicole E Lopez; Cristina Prendergast; Andrew M Lowy
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

5.  A Novel Prognostic Score Combining Preoperative Biliary Drainage and Inflammatory Status for Patients with Periampullary Cancers.

Authors:  Yuki Fujiwara; Koichiro Haruki; Ryoga Hamura; Takashi Horiuchi; Yoshihiro Shirai; Kenei Furukawa; Takeshi Gocho; Hiroaki Shiba; Katsuhiko Yanaga
Journal:  J Gastrointest Surg       Date:  2019-05-06       Impact factor: 3.452

6.  Clinical and pathologic features influencing survival in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma.

Authors:  Cynthia E Weber; Eileen A Bock; Michael G Hurtuk; Gerard J Abood; Jack Pickleman; Margo Shoup; Gerard V Aranha
Journal:  J Gastrointest Surg       Date:  2013-11-23       Impact factor: 3.452

7.  Novel toll-like receptor 2 ligands for targeted pancreatic cancer imaging and immunotherapy.

Authors:  Amanda Shanks Huynh; Woo Jin Chung; Hyun-Il Cho; Valerie E Moberg; Esteban Celis; David L Morse; Josef Vagner
Journal:  J Med Chem       Date:  2012-11-08       Impact factor: 7.446

Review 8.  Intensity of follow-up after pancreatic cancer resection.

Authors:  Jason A Castellanos; Nipun B Merchant
Journal:  Ann Surg Oncol       Date:  2013-10-04       Impact factor: 5.344

9.  Pancreaticoduodenectomy with combined superior mesenteric vein resection without reconstruction is possible: A case report and review of the literature.

Authors:  Lionel Jouffret; Theophile Guilbaud; Olivier Turrini; Jean-Robert Delpero
Journal:  World J Clin Cases       Date:  2018-08-16       Impact factor: 1.337

Review 10.  Pancreatic cancer: Open or minimally invasive surgery?

Authors:  Yu-Hua Zhang; Cheng-Wu Zhang; Zhi-Ming Hu; De-Fei Hong
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.